A large-scale transgenic RNAi screen identifies transcription factors that modulate myofiber size in Drosophila.
Myofiber atrophy occurs with aging and in many diseases but the underlying mechanisms are incompletely understood. Here, we have used >1,100 muscle-targeted RNAi interventions to comprehensively assess the function of 447 transcription factors in the developmental growth of body wall skeletal mus...
Main Authors: | Flavia A Graca, Natalie Sheffield, Melissa Puppa, David Finkelstein, Liam C Hunt, Fabio Demontis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-11-01
|
Series: | PLoS Genetics |
Online Access: | https://doi.org/10.1371/journal.pgen.1009926 |
Similar Items
-
The myokine Fibcd1 is an endogenous determinant of myofiber size and mitigates cancer-induced myofiber atrophy
by: Flavia A. Graca, et al.
Published: (2022-05-01) -
A Key Role for the Ubiquitin Ligase UBR4 in Myofiber Hypertrophy in Drosophila and Mice
by: Liam C. Hunt, et al.
Published: (2019-07-01) -
Validating RNAi phenotypes in Drosophila using a synthetic RNAi-resistant transgene.
by: Vincent Jonchere, et al.
Published: (2013-01-01) -
Antagonistic control of myofiber size and muscle protein quality control by the ubiquitin ligase UBR4 during aging
by: Liam C. Hunt, et al.
Published: (2021-03-01) -
An efficient and multiple target transgenic RNAi technique with low toxicity in Drosophila
by: Huan-Huan Qiao, et al.
Published: (2018-10-01)